Profile
ABCM NVO VRTX REGN MRNA SGEN
Company Name Abcam plc Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Moderna, Inc. Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $5.52B $564.11B $108.23B $104.90B $47.02B $43.15B
Employees 1.76K 66.02K 5.40K 13.68K 5.60K 3.26K
CEO Mr. Alan Thomas Hirzel BS, M.B.A., M.S. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. Stephane Bancel Mr. David R. Epstein B.Sc., M.B.A.
Ratings
ABCM NVO VRTX REGN MRNA SGEN
Quant Rating Score 5 5 5 2 3
Quant Rating Strong Buy Strong Buy Strong Buy Sell Neutral
Trading
ABCM NVO VRTX REGN MRNA SGEN
Last Close $23.99 $128.42 $422.78 $973.8 $117.31 $228.74
High 52 $24.47 $199.54 $446.08 $993.35 $137.75 $228.9
Low 52 $16.04 $87.78 $323.57 $692.45 $69.51 $187.64
Price vs. 52 Week High -1.96 % -35.64 % -5.22 % -1.97 % -14.84 % -0.07 %
Price vs. 52 Week Low 49.56 % 46.3 % 30.66 % 40.63 % 68.77 % 21.9 %
Total Return
ABCM NVO VRTX REGN MRNA SGEN
1 Month Return 0 % 2.41 % 5.63 % 5.81 % 9.63 % 0 %
3 Month Return 0 % 5.96 % -0.03 % 2.14 % 34.21 % 0 %
6 Month Return 3.76 % 26.91 % 13.15 % 21.89 % 67.47 % 7.03 %
9 Month Return 2.96 % -29.28 % 20.84 % 20.68 % 15.59 % 17.5 %
YTD Return 0 % 24.14 % 3.91 % 10.87 % 17.96 % 0 %
1 Year Return 34.47 % -24.01 % 20.66 % 30.61 % -8.64 % 14.66 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABCM NVO VRTX REGN MRNA SGEN
Dividend Yield Percentage (TTM) - 0.15 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) 0.93 % 1.1 % 13.85 % 6.2 % -3.65 % -3.35 %
Dividend Per Share (TTM) - 0.2 % - - - -
Payout Ratio (TTM) 2272.73 % 47.03 % - - - -
Growth
ABCM NVO VRTX REGN MRNA SGEN
Asset Growth 7.15 % 30.35 % 25.23 % 13.23 % -28.74 % -1.21 %
Gross Profit Growth 20.44 % 32.32 % 9.25 % 6.49 % -85.12 % 22.93 %
Revenue Growth 14.68 % 31.26 % 10.17 % 7.76 % -64.94 % 24.65 %
Revenue 3 Year 27.5 % 90.51 % 59.87 % 55.67 % 2356.27 % 91.84 %
Revenue 5 Year 39.57 % 124.2 % 218.58 % 110.3 % 1070.62 % 215.48 %
Revenue 10 Year 155.91 % 66.11 % 608.27 % 549.62 % 6447.35 % 494.04 %
EBIT Growth -243.66 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Net Income Growth -293.18 % 50.71 % 8.96 % -8.87 % -156.37 % 9.51 %
Net Income 3 Yeari Growth Per Share -162.32 % 106.79 % 34.59 % 13.48 % -529.9 % -764.83 %
Net Income 5 Yeari Growth Per Share -112.3 % 133.86 % 70.33 % 74.02 % -160.17 % -276.93 %
Net Income 10 Yeari Growth Per Share -122.5 % 98.61 % 809.6 % 871.12 % -2046.03 % -624.16 %
Operating Income Growth -243.66 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Operating Cash Flow Growth (CFG) -54.37 % 38.06 % -14.35 % -8.39 % -162.6 % 9.07 %
Operating 3 Year CFG -58.25 % 118.29 % 9.63 % 76.95 % -253.56 % -148.34 %
Operating 5 Year CFG -59.2 % 163.51 % 174.78 % 125.17 % -100.11 % -195.86 %
Operating 10 Year CFG -37.07 % 150.92 % 5187.08 % 713.56 % -4698.89 % -2622.09 %
EPS Growth -295.79 % 52.28 % 8.33 % -8.54 % -158.15 % 10.81 %
EPS Diluted Growth -293.75 % 52.37 % 8.35 % -9.03 % -161.39 % 10.81 %
Book Value Per Share 10.89 % 29 % 25.58 % 15.03 % -25.28 % -9.83 %
Share Holder 3 Year Equity Growth Per Share 32.55 % 75.22 % 104.06 % 137.56 % 439.94 % 33.92 %
Share Holder 5 Year Equity Growth Per Share 85.99 % 121.9 % 291.14 % 219.1 % 92.24 % 220.81 %
Share Holder 10 Year Equity Growth Per Share 269.11 % 49.62 % 1030.79 % 1286.9 % 1519.81 % 691.19 %
Dividend Per Share Growth 0.09 % 26.89 % - - - -
Dividend 3 Year Growth Per Share -8.35 % 64.4 % - - - -
Dividend 5 Year Growth Per Share 1.8 % - - - - -
Dividend 10 Year Growth Per Share 72.85 % 95.44 % - - - -
Debt Growth -2.53 % 4.74 % 44.1 % 0.06 % 3.58 % -23.28 %
Free Cash Flow Growth -506.45 % 9.17 % -16.47 % -17.11 % -183.5 % 3.67 %
Updated On 31 Dec 2022 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022
Profitability
ABCM NVO VRTX REGN MRNA SGEN
Gross Profit Margin TTM 77.89 % 84.65 % 86.91 % 87.16 % 21.77 % 75.4 %
Return on Assets TTM 0.03 % 29.87 % 16.81 % 11.22 % -35.67 % -20.64 %
Return on Equity TTM 0.04 % 91.82 % 23.61 % 15.15 % -41.83 % -28.06 %
Return on Capital Employed TTM 5.69 % 82.5 % 21.07 % 12.53 % -35.81 % -29.5 %
Net Income Per EBT TTM 4.91 % 79.81 % 84.31 % 95.44 % 124.28 % 101.53 %
EBT Per Ebit TTM 11.75 % 101.7 % 112.45 % 104.74 % 93.44 % 93.47 %
EBIT Per Revenue TTM 10.41 % 45.03 % 41.62 % 29.46 % -99.69 % -34.37 %
Cash Flow To Debt Ratio TTM 12.07 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Receivables Turnover TTM 4.22 3.87 5.68 2.51 13.32 3.64
Payables Turnover TTM 1.65 2.88 0.42 2.51 22.04 2.52
Inventory Turnover TTM 1.53 1.12 1.64 0.62 13.67 1.07
Fixed Asset Turnover TTM 290.89 % 248.64 % 685.54 % 310.02 % 186.78 % 471.71 %
Asset Turnover TTM 44.61 % 81.71 % 42.58 % 38.12 % 30.81 % 63.3 %
Operating Cash Flow Per Share TTM 0.11 20.95 15.27 43.96 -7.54 -2.87
Free Cash Flow Per Share TTM 0.02 11.28 14.17 36.87 -9.61 -3.73
Cash Per Share TTM 33.95 % 208.61 % 3939.31 % 9758.35 % 2235.6 % 657.5 %
Operating Cash Flow Sales Ratio TTM 5.72 % 38.24 % 38.72 % 36.17 % -55.91 % -23.48 %
Free Cash Flow Operating Cash Flow Ratio TTM 16.03 % 53.85 % 92.78 % 83.87 % 127.41 % 129.82 %
Cash Flow Coverage Ratios TTM 12.07 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Price To Free Cash Flows Ratio TTM 1049.38 77.58 29.58 26.39 -12.8 -61.54
Price To Operating Cash Flows Ratio TTM 170.08 42.5 27.43 22.02 -16.26 -79.67
Price Cash Flow Ratio TTM 170.08 42.5 27.43 22.02 -16.26 -79.67
Income Statement (TTM)
ABCM NVO VRTX REGN MRNA SGEN
Revenue $0.36B $232.26B $9.84B $13.12B $6.75B $1.96B
Gross Profit $0.27B $196.5B $8.58B $11.3B $2.06B $1.55B
Gross Profit Ratio 74.79% 84.6% 87.17% 86.16% 30.52% 79.1%
EBITDA $0.04B $112.94B $3.93B $5.13B $-3.21B $-0.62B
Net Income $-0.01B $83.68B $3.62B $3.95B $-4.71B $-0.61B
EPS Diluted -0.04 18.62 13.89 34.77 -12.34 -3.3
Balance Sheet (MRQ)
ABCM NVO VRTX REGN MRNA SGEN
Long Term Debt $0.1B $20.53B $0.72B $2.7B $1.22B $0.04B
Total Liabilities $0.33B $207.93B $5.15B $7.11B $4.57B $0.87B
Total Equity $0.73B $106.56B $17.58B $25.97B $13.85B $2.8B
Total Investments $0B $17.5B $3.45B $13.51B $4.68B $1.42B
Total Debt $0.22B $27.01B $0.81B $2.7B $1.24B $0.04B
Total Assets $1.06B $314.49B $22.73B $33.08B $18.43B $3.67B
Cash Flow Statement (TTM)
ABCM NVO VRTX REGN MRNA SGEN
Net Income $-0.01B $83.68B $3.62B $3.95B $-4.71B $-0.61B
Inventory $-0.01B $-7.42B $-0.32B $-0.27B $0.75B $-0.23B
Dividends Paid $-0.03B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $0.03B $108.91B $3.54B $4.59B $-3.12B $-0.45B
Capital Expenditure $-0.04B $-38.9B $-0.26B $-0.93B $-0.71B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.78
ABCL AbCellera Biologics Inc. 3.83
ABEO Abeona Therapeutics Inc. 4.2
ABIO ARCA biopharma, Inc. 3.47
ABOS Acumen Pharmaceuticals, Inc. 3.36
ABSI Absci Corporation 4.91
ABUS Arbutus Biopharma Corporation 2.88
ABVC ABVC BioPharma, Inc. 1.06
ABVX Abivax SA American Depositary Shares 14.09
ACAD ACADIA Pharmaceuticals Inc. 15.25
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 1.47
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.9401
ACHV Achieve Life Sciences, Inc. 4.61
ACIU AC Immune SA 2.31
ACLX Arcellx, Inc. 49.74
ACRV Acrivon Therapeutics, Inc. Common Stock 8.77
ACST Acasti Pharma Inc. 2.76
ACXP Acurx Pharmaceuticals, Inc. 2.03
ETFs With Exposure to ABCM
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.40175 133.4
SPDW SPDR Portfolio Developed World ex-US ETF 0.033598 35.97
BIB ProShares Ultra Nasdaq Biotechnology 0.189373 54.47
MNA IQ Merger Arbitrage ETF 6.85 31.0556
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 64.34
FPXI First Trust International Equity Opportunities ETF 0.45 46.56
ISCF iShares MSCI Intl Small-Cap Multifactor ETF 0.18111 33.195
MRGR ProShares Merger ETF 3.16608 39.8995
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.27 25.15
VINEX Vanguard International Explorer Fund Investor Shares 0.22 17.33
VGHAX Vanguard Health Care Fund Admiral Shares 0.36 89.79
VGHCX Vanguard Health Care Fund Investor Shares 0.36 212.95
BMED BlackRock Future Health ETF 1.68229 25.08
IBBQ Invesco Nasdaq Biotechnology ETF 0.539 21.69
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.48139 5.828
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.53798 6.2875
DFIC Dimensional International Core Equity 2 ETF 0.00052105 27.005
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.53798 6.308
CTRU ARK Transparency ETF 0.96 12.897
Unlock